Serial biotech founder George Church has a new startup, and this time, he has skin in the game, quite literally.

Renowned Harvard geneticist and serial entrepreneur George Church is at it again, with a venture that has raised $75 million ...

The Federal Reserve yesterday cut interest rates by 50 basis points, in its first time cutting rates in four years. And how ...

Selling plaque psoriasis drug Vtama to Organon looks like another win for Roivant, which has been buying overlooked drugs, ...

Tarsus Pharmaceuticals is expanding its pipeline to target meibomian gland disease and rosacea, with promising Phase 2 ...

GC Therapeutics has entered gameplay with the mission of unlocking a new generation of cell therapies, uploading with $75 ...

Evonik has developed a groundbreaking model of the skin microbiome that allows for realistic, scientifically validated ...

The end of the trading week likely can't come fast enough for Vanda Pharmaceuticals ( VNDA -6.06%). The commercial-stage ...

The palms of our hands and the bottoms of our feet aren’t the flashiest body parts, but they have a secret superpower that we don’t often appreciate—the ability to bear weight. | For those with ...

CGMs are small patch-like wearable medical devices that use biosensor wires under the skin to measure glucose in real-time. These devices are increasingly popular in diabetes management and health ...

Alteogen overtakes EcoPro BM, South Korea’s largest producer of cathodes for EV batteries, to become the biggest company on the Kosdaq by market capitalization.

The FDA has approved Roche's Ocrevus Zunovo for relapsing and primary progressive multiple sclerosis, offering the first ...